Article Versions Notes

van Caloen G, Schmitz S, van Marcke C, Caignet X, Mendola A, Pyr dit Ruys S, Roger PP, Vertommen D, Machiels J-P. Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and Neck. Cancers. 2021; 13(6):1251. https://doi.org/10.3390/cancers13061251

van Caloen, Gabrielle, Sandra Schmitz, Cédric van Marcke, Xavier Caignet, Antonella Mendola, Sébastien Pyr dit Ruys, Pierre P. Roger, Didier Vertommen, and Jean-Pascal Machiels. 2021. "Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and Neck" Cancers 13, no. 6: 1251. https://doi.org/10.3390/cancers13061251

van Caloen, G., Schmitz, S., van Marcke, C., Caignet, X., Mendola, A., Pyr dit Ruys, S., Roger, P. P., Vertommen, D., & Machiels, J.-P. (2021). Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and Neck. Cancers, 13(6), 1251. https://doi.org/10.3390/cancers13061251